Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Plasmodium gametocyte is the sexual precursor cell of malaria parasites, differentiated from asexual blood-stage forms. Gametocytes are highly specialized: males (microgametocytes) undergo endomitosis to produce flagellated microgametes upon transmission to the mosquito, while females (macrogametocytes) are prepared for fertilization and further development in the vector[5]. The stage is morphologically distinct, especially for *P. falciparum*, which forms the classic crescent-shaped gametocyte through complex remodeling of membrane compartments (inner membrane complex) and cytoskeletal elements (microtubules and actin filaments)[1][2][6][7]. Gametocytes do not directly cause malaria symptoms but are essential for transmission from human hosts to mosquitoes, making them a key focus for development of transmission-blocking interventions[5]. Drugs that target gametocytes can prevent dissemination of malaria in endemic regions. The biology of gametocytes involves extensive structural rearrangements, dimorphic sex differentiation, and specialized organellar architectures, all supporting their survival, release into the bloodstream, and readiness for mosquito uptake[1][2][3][6]. Note: "Plasmodium gametocyte" should not be confused with specific proteins, receptors, or enzymes; it is a cellular stage, and therapeutic targeting is aimed at killing or preventing maturation of these cells in humans to block malaria transmission[5].
Direct gametocytocidal activity (kills gametocytes in human blood, preventing transmission); Inhibition of gametocyte maturation; Disruption of mitochondrial function
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Plasmodium gametocyte.